U.S. Markets open in 5 hrs 26 mins

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Zacks Equity Research

Esperion Therapeutics, Inc. ESPR was a big mover last session, as its shares rose a little over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $10.50 to $11.68 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Esperion Therapeutics currently carries a Zacks Rank #3 (Hold).




A better-ranked stock in the med-drugs space is Acerus Pharmaceuticals Corporation TRLPF, which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ESPR going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ESPERION THERAP (ESPR): Free Stock Analysis Report
ACERUS PHARMS (TRLPF): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research